Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
Last action on Feb 6, 2015Referred to the Subcommittee on Health.
Take Action
Summary
Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.
Lifecycle of the Bill
No events recorded for this stage yet.
